1. INTRODUCTION
1.1. Market Overview
1.2. Market Definition
1.3. Scope of the Study
1.4. Market Segmentation
1.5. Currency
1.6. Assumptions
1.7. Base, and Forecast Years Timeline
2. RESEARCH METHODOLOGY
2.1. Research Data
2.2. Assumptions
3. EXECUTIVE SUMMARY
3.1. Research Highlights
4. MARKET DYNAMICS
4.1. Market Drivers
4.2. Market Restraints
4.3. Porter’s Five Force Analysis
4.3.1. Bargaining Power of Suppliers
4.3.2. Bargaining Power of Buyers
4.3.3. Threat of New Entrants
4.3.4. Threat of Substitutes
4.3.5. Competitive Rivalry in the Industry
4.4. Industry Value Chain Analysis
5. EUROPE CONTINUOUS GLUCOSE MONITORING (CGM) MARKET, BY APPLICATION
5.1. Introduction
5.2. Diabetes Patients
5.3. Critical Patients
6. EUROPE CONTINUOUS GLUCOSE MONITORING (CGM) MARKET, BY END-USER INDUSTRY
6.1. Introduction
6.2. Hospitals
6.3. Diagnostic Centers & Clinics
6.4. Home Care
7. EUROPE CONTINUOUS GLUCOSE MONITORING (CGM) MARKET, BY geography
7.1. Germany
7.2. Spain
7.3. France
7.4. UK
7.5. Others
8. COMPETITIVE ENVIRONMENT AND ANALYSIS
8.1. Major Players and Strategy Analysis
8.2. Emerging Players and Market Lucrativeness
8.3. Mergers, Acquisitions, Agreements, and Collaborations
8.4. Vendor Competitiveness Matrix
9. COMPANY PROFILES
9.1. Dexcom, Inc.
9.2. Abbott Laboratories
9.3. Medtronic plc
9.4. Roche Diabetes Care, Inc.
9.5. GlucoMen
9.6. Diabeloop
9.7. Tandem Diabetes Care, Inc.
9.8. Ypsomed AG
9.9. Diabetizer GmbH & Co. KG